Robin Shane Readnour

Director, AN2 Therapeutics, Inc.

Bought, 12 months

$0.0M

Sold, 12 months

$0.3M

Companies

Latest trade

Sep 9, 2026

Companies

AN2 Therapeutics, Inc.Director −$0.3M

Trades

ANTX Sold 1,108 shares at $6.02 · planned $0.0M Sep 9

ANTX Sold 10,019 shares at $6.02 · planned $0.1M Sep 8

ANTX Sold 6,100 shares at $6.07 · planned $0.0M Sep 3

ANTX Sold 35,402 shares at $6.01 · planned $0.2M Aug 17

Open-market trades from SEC Form 4 only: no grants, option exercises or gifts. People are matched by the name on their filings, so two people with the same name share this page. For information only — not investment advice.